NDUFB9 Antikörper (C-Term)

Produktnummer ABIN500208

Produktdetails anti-NDUFB9 Antikörper

Target: NDUFB9 (NADH Dehydrogenase (Ubiquinone) 1 beta Subcomplex, 9, 22kDa (NDUFB9))

Bindungsspezifität: C-Term

Reaktivität: Human, Maus, Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser NDUFB9 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Enzyme Immunoassay (EIA)

Kreuzreaktivität (Details): Species reactivity (tested):Human, mouse, rat

Aufreinigung: Peptide affinity chromatography

Immunogen: LYRM3 antibody was raised against a 17 amino acid peptide near the carboxy terminus of human LYRM3.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: ELISA. Western blot: 1 - 2 μg/mL.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 1.0 mg/mL

Buffer: PBS containing 0.02 % sodium azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid repeated freezing and thawing.

Lagerung: -20 °C

Informationen zur Lagerung: Store the antibody (in aliquots) at -20 °C.

Details zu NDUFB9

Target: NDUFB9 (NADH Dehydrogenase (Ubiquinone) 1 beta Subcomplex, 9, 22kDa (NDUFB9))

Andere Bezeichnung: NDUFB9 (NDUFB9 Produkte)

Synonyme: 1190008J14Rik antikoerper, B22 antikoerper, CI-B22 antikoerper, LYRM3 antikoerper, UQOR22 antikoerper, NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9 antikoerper, NADH:ubiquinone oxidoreductase subunit B9 antikoerper, Ndufb9 antikoerper, NDUFB9 antikoerper

Hintergrund: LYRM3, also known as NADH dehydrogenase (ubiquinone) 1 beta subcomplex 9 (NDUFB9), is a ubiquitously expressed LYR-motif containing protein. It has been suggested to be a candidate gene for the branchio-oto-renal (BOR) syndrome, which is characterized by branchial and renal abnormalities and heredity deafness disorders. Other than its LYR-motif, LYRM3 appears to have no functional or structural relationship to either LYRM1 or LYRM2.Synonyms: Complex I-B22, LYR motif-containing protein 3, LYRM3, NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9, NADH-ubiquinone oxidoreductase B22, UQOR22

Gen-ID: 4715

UniProt: Q9Y6M9

Pathways: Sensory Perception of Sound, SARS-CoV-2 Protein Interaktom